Search Results 151-160 of 27419 for Two-phase

  1. Alzheimer's stages: How the disease progresses - Mayo Clinic

    Alzheimer's stages: How the disease progresses · Preclinical Alzheimer's disease. · Mild cognitive impairment due to Alzheimer's disease. · Mild dementia due to ...

  2. Non-Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research

    The Dose Escalation Phase will determine the Maximum Tolerated Dose (MTD) and recommended Phase 2 dose (RP2D) of PT-112 in the combination as avelumab will be ...

  3. New treatment option for early type 1 diabetes - Mayo Clinic

    ... stages: Stage 1: two or more positive diabetes autoantibodies but normal blood glucose levels. Stage 2: two or more positive diabetes autoantibodies and ...

  4. Neurology - Clinical trials

    To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...

  5. Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side ... Phase 2: ≥ stage IB. Stage of disease according to Tumor-Node-Metastasis ...

  6. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

    LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High ...

  8. Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability of and to define the maximum tolerated dose (MTD) and Recommended Phase 2 Dose (RP2D); and ...

  9. Myelodysplastic Syndromes Clinical Trials - Mayo Clinic Research

    This study will be conducted in two phases. In phase 1 subjects will be randomized into 3 cohorts in a 28-day cycles. Phase 2, 80 new subjects will be ...

  10. Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients

    Clinical Trials · Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients.